Royalty Pharma

RPRX · NASDAQ

$62.25+$1.98 (+3.29%)TodayMarket closed ·
Prev close $60.27

Who owns RPRX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 32.5% of RPRX’s shares.

  • Morgan Stanley Investment Management Inc. (US)6.5%
  • Capital International Investors6.1%
  • Nogra Group Sicaf SIF S.A.3.7%
  • Fidelity Management & Research Company LLC3.7%
  • Next 6 largest institutions12.5%
  • All other shareholders67.5%
Top institutional holders of RPRX
HolderShares% of shares
Morgan Stanley Investment Management Inc. (US)37.31M6.48%
Capital International Investors35.27M6.13%
Nogra Group Sicaf SIF S.A.21.37M3.71%
Fidelity Management & Research Company LLC21.24M3.69%
BlackRock Institutional Trust Company, N.A.18.75M3.26%
State Street Investment Management (US)12.34M2.14%
T. Rowe Price Associates, Inc.10.77M1.87%
Swedbank Robur Fonder AB10.73M1.86%
Baillie Gifford & Co.10.02M1.74%
Capital World Investors9.52M1.65%

Largest mutual fund holders

Top mutual fund holders of RPRX
HolderShares% of shares
American Funds New Perspective Fund19.65M3.41%
American Funds Capital Income Builder8.58M1.49%
American Funds Growth Fund of America7.58M1.32%
Statens Pensjonsfond Utland5.83M1.01%
MS INVF US Advantage Fund5.57M0.97%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $36.06M (20 trades) of RPRX on the open market, with no buys.

Latest RPRX insider transactions
InsiderTypeSharesValue
Urist MarshallSale4.13K$235.59K
Hite ChristopherSale3.93K$231.40K
Hite ChristopherSale96.07K$5.62M
Hite ChristopherGift16.80K—
Hite ChristopherSale100.00K$6.00M
Coyne Terrance P.Sale1.77K$104.80K
Coyne Terrance P.Sale9.23K$540.75K
Urist MarshallGift3.00K—
Coyne Terrance P.Gift18.50K—
Legorreta Pablo G.Gift30.00K—

Short interest

Settled Sep 30, 2026

Shares short
12.89M
Days to cover
4.44
% of shares outstanding
2.24%
Average daily volume
2.90M
Change since last report
+10.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.